Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy.

Multiple Sclerosis : Clinical and Laboratory Research
Nathaniel LizakTomas Kalincik

Abstract

Observational clinical data from cladribine-treated patients with relapsing forms of multiple sclerosis (MS) were recorded in the Australian MS registry powered by the MSBase registry platform (5-year follow-up) and analysed to complement information from the pivotal cladribine clinical trials in MS. A cohort of 90 cladribine-treated patients with follow-up data reported by treating physicians and recorded in the Australian MSBase registry (database lock February 2016) were examined. Clinical data included Expanded Disability Status Scale (EDSS) scores, relapses and other disease-modifying drugs (DMDs) administered before and after cladribine treatment. Mean age on starting cladribine was 47 years; mean age at MS onset was 34 years, and median baseline EDSS score was 5.25. Disability trajectories in patients with sufficient follow-up suggested an overall increasing trend prior to cladribine treatment which was reduced during the 2-year post-treatment. Approximately 80% of patients were EDSS progression-free, 65% remained relapse-free after 2 years and median time to next DMD was 1.7 years. These observational data suggest a disease-modifying effect in this cohort of relapsing MS patients characterised by older and more disabled...Continue Reading

References

Feb 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·H ButzkuevenJ P Malkowski
Jan 22, 2010·The New England Journal of Medicine·Gavin GiovannoniUNKNOWN CLARITY Study Group
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Dec 25, 2012·Journal of Neurology·Giancarlo ComiSteven J Greenberg
Feb 5, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Ilana Katz SandAaron E Miller
Jan 1, 2012·Multiple Sclerosis and Related Disorders·Kottil RammohanNuwan Kurukulasuriya
Aug 5, 2015·Journal of Neurology·Hans-Peter HartungChristoph Pohl
Sep 12, 2015·Brain : a Journal of Neurology·Tomas KalincikHelmut Butzkueven
Jun 9, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Tomas Kalincik, Helmut Butzkueven
Jul 13, 2016·Brain : a Journal of Neurology·Johannes LorscheiderUNKNOWN MSBase Study Group
Aug 3, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Tomas KalincikUNKNOWN MSBase Scientific Leadership Group and MSBase Study Group
Jun 14, 2017·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Anthony L TraboulseeDavid Kb Li
Sep 1, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Tomas KalincikUNKNOWN MSBase Study Group
Oct 21, 2017·Multiple Sclerosis Journal - Experimental, Translational and Clinical·Mark S FreedmanFernando Dangond
Jan 30, 2018·Australian Prescriber·Greg Kyle
Mar 20, 2018·Journal of Neurology·Bryan CeronieKlaus Schmierer
Jul 22, 2018·Neurology. Neuroimmunology and Neuroinflammation·Xavier MontalbanFernando Dangond
Nov 13, 2018·Multiple Sclerosis and Related Disorders·Zhifeng MaoKlaus Schmierer
Feb 21, 2019·Multiple Sclerosis and Related Disorders·David BakerKlaus Schmierer
Mar 20, 2019·Multiple Sclerosis and Related Disorders·Stuart CookElke Sylvester
Apr 5, 2019·Therapeutic Advances in Neurological Disorders·Per Soelberg Sorensen, Finn Sellebjerg
Jun 28, 2019·Therapeutic Advances in Neurological Disorders·Olaf StuveUrsula Boschert

❮ Previous
Next ❯

Citations

Feb 2, 2021·Neurodegenerative Disease Management·Augusto A MiravalleEdward J Fox
Jul 15, 2021·Multiple Sclerosis and Related Disorders·Martin StangelStephan Schmidt

❮ Previous
Next ❯

Software Mentioned

CLARITY
ONWARD
ORACLE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Multiple Sclerosis : Clinical and Laboratory Research
J C SipeE Beutler
Journal of Neurology, Neurosurgery, and Psychiatry
Benjamin Meir JacobsKlaus Schmierer
Neurology. Neuroimmunology and Neuroinflammation
Leoni RolfesRefik Pul
© 2022 Meta ULC. All rights reserved